Skinopathy Files Provisional Patent for Artificial Intelligence and Augmented Reality Powered Technology that will Guide Skin Cancer Surgeries TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Skinopathy, a Canadian medical company founded in 2020, has filed a provisional patent with the United States Patent and Trademark Office (USPTO) for...

AiViva Biopharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer NEWPORT BEACH, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun dosing patients diagnosed with superficial or...